Fallopian Tube Cancer Prognosis

Last Modified: January 22, 2006


Dear OncoLink "Ask The Experts,"

I was diagnosed with Stage 1A fallopian tube cancer in July. The surgery was performed by a surgeon specializing in GYN Oncology. Why does your website say that the 5-year survival rate for Stage 1A is 51% (or thereabouts), whereas all other websites I've found quote 91% 5-year survival for Stage 1A fallopian tube cancer?


Carolyn Vachani RN, MSN, AOCN, OncoLink's Nurse Educator, responds:

The numbers we have posted are what most oncology textbooks quote, which are based on some older clinical studies. In these studies, fallopian tube cancer stage I patients did not receive any adjuvant therapy (meaning chemotherapy after surgery). Stage I tumors invade the mucosa, although they do not penetrate it. According to our experts, nowadays it is generally thought and recommended that stage I patients receive some adjuvant chemotherapy. With this additional therapy, properly-staged 1A patients could have 5-year survival in the 80-90% range. There are only about 300 total cases of fallopian tube cancer a year (this includes all stages). These small numbers have not allowed for many controlled studies to get accurate prognostic information from, so this 80-90% range is more based on expert opinion, not necessarily hard data.


How to Find the Cancer Resources You Need - Brown Bag Web Chat
by OncoLink Editorial Team
June 15, 2011

Medicinal Mushrooms – Support and Safety During Breast Cancer
by The 4Wholeness Team
September 29, 2015

Related News

Nonselective Beta-Blocker Use Ups Survival in Ovarian Cancers

Aug 24, 2015

Longer median overall survival for patients receiving any beta-blocker versus nonusers

Earlier Ovary Removal Provides Greatest BRCA-Associated Benefit

Feb 26, 2014

In particular, women with BRCA1 mutation should have surgery by age 35, researchers say

ASCO: Pazopanib Ups Survival in Advanced Ovarian Cancer

Jun 4, 2013

Maintenance therapy linked to longer progression-free survival after surgery for advanced disease